137 related articles for article (PubMed ID: 36087560)
41. Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.
Ossenkoppele R; Lyoo CH; Jester-Broms J; Sudre CH; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; La Joie R; Rabinovici GD; Hansson O
JAMA Neurol; 2020 May; 77(5):632-642. PubMed ID: 32091549
[TBL] [Abstract][Full Text] [Related]
42. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
[TBL] [Abstract][Full Text] [Related]
43. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.
Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z;
Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025
[TBL] [Abstract][Full Text] [Related]
44. Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.
Risacher SL; McDonald BC; Tallman EF; West JD; Farlow MR; Unverzagt FW; Gao S; Boustani M; Crane PK; Petersen RC; Jack CR; Jagust WJ; Aisen PS; Weiner MW; Saykin AJ;
JAMA Neurol; 2016 Jun; 73(6):721-32. PubMed ID: 27088965
[TBL] [Abstract][Full Text] [Related]
45. Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings.
Toledo JB; Bjerke M; Chen K; Rozycki M; Jack CR; Weiner MW; Arnold SE; Reiman EM; Davatzikos C; Shaw LM; Trojanowski JQ;
Neurology; 2015 Jul; 85(2):144-53. PubMed ID: 26085606
[TBL] [Abstract][Full Text] [Related]
46. Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia.
Jack CR; Wiste HJ; Therneau TM; Weigand SD; Knopman DS; Mielke MM; Lowe VJ; Vemuri P; Machulda MM; Schwarz CG; Gunter JL; Senjem ML; Graff-Radford J; Jones DT; Roberts RO; Rocca WA; Petersen RC
JAMA; 2019 Jun; 321(23):2316-2325. PubMed ID: 31211344
[TBL] [Abstract][Full Text] [Related]
47. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.
den Heijer T; Geerlings MI; Hoebeek FE; Hofman A; Koudstaal PJ; Breteler MM
Arch Gen Psychiatry; 2006 Jan; 63(1):57-62. PubMed ID: 16389197
[TBL] [Abstract][Full Text] [Related]
48. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
[TBL] [Abstract][Full Text] [Related]
49. Responsiveness of magnetic resonance imaging and neuropsychological assessment in memory clinic patients.
Schmand B; Rienstra A; Tamminga H; Richard E; van Gool WA; Caan MW; Majoie CB
J Alzheimers Dis; 2014; 40(2):409-18. PubMed ID: 24473187
[TBL] [Abstract][Full Text] [Related]
50. How Do Different Forms of Vascular Brain Injury Relate to Cognition in a Memory Clinic Population: The TRACE-VCI Study.
Boomsma JMF; Exalto LG; Barkhof F; van den Berg E; de Bresser J; Heinen R; Leeuwis AE; Prins ND; Scheltens P; Weinstein HC; van der Flier WM; Biessels GJ;
J Alzheimers Dis; 2019; 68(3):1273-1286. PubMed ID: 30909212
[TBL] [Abstract][Full Text] [Related]
51. A 'Comprehensive Visual Rating Scale' for predicting progression to dementia in patients with mild cognitive impairment.
Jang JW; Park JH; Kim S; Park YH; Pyun JM; Lim JS; Kim Y; Youn YC; Kim S;
PLoS One; 2018; 13(8):e0201852. PubMed ID: 30125290
[TBL] [Abstract][Full Text] [Related]
52. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
[TBL] [Abstract][Full Text] [Related]
53. Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline.
Dark HE; An Y; Duggan MR; Joynes C; Davatzikos C; Erus G; Lewis A; Moghekar AR; Resnick SM; Walker KA
Alzheimers Res Ther; 2024 Apr; 16(1):94. PubMed ID: 38689358
[TBL] [Abstract][Full Text] [Related]
54. Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline.
Ten Kate M; Dicks E; Visser PJ; van der Flier WM; Teunissen CE; Barkhof F; Scheltens P; Tijms BM;
Brain; 2018 Dec; 141(12):3443-3456. PubMed ID: 30351346
[TBL] [Abstract][Full Text] [Related]
55. Callosal circularity as an early marker for Alzheimer's disease.
Van Schependom J; Niemantsverdriet E; Smeets D; Engelborghs S
Neuroimage Clin; 2018; 19():516-526. PubMed ID: 29984160
[TBL] [Abstract][Full Text] [Related]
56. Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia.
Koenig LN; Day GS; Salter A; Keefe S; Marple LM; Long J; LaMontagne P; Massoumzadeh P; Snider BJ; Kanthamneni M; Raji CA; Ghoshal N; Gordon BA; Miller-Thomas M; Morris JC; Shimony JS; Benzinger TLS;
Neuroimage Clin; 2020; 26():102248. PubMed ID: 32334404
[TBL] [Abstract][Full Text] [Related]
57. Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences Neuroimaging Criteria in Alzheimer's Disease with Concomitant Cerebral Infarction.
Sheng B; Cheng LF; Law CB; Li HL; Yeung KM; Lau KK
J Am Geriatr Soc; 2007 Jun; 55(6):918-22. PubMed ID: 17537094
[TBL] [Abstract][Full Text] [Related]
58. Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.
Vassilaki M; Crowson CS; Davis Iii JM; Duong SQ; Jones DT; Nguyen A; Mielke MM; Vemuri P; Myasoedova E
J Alzheimers Dis; 2022; 89(3):943-954. PubMed ID: 35964191
[TBL] [Abstract][Full Text] [Related]
59. Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors.
Sluimer JD; Vrenken H; Blankenstein MA; Fox NC; Scheltens P; Barkhof F; van der Flier WM
Neurology; 2008 May; 70(19 Pt 2):1836-41. PubMed ID: 18458218
[TBL] [Abstract][Full Text] [Related]
60. Predictors of progression from mild cognitive impairment to dementia in the placebo-arm of a clinical trial population.
Prins ND; van der Flier WM; Brashear HR; Knol DL; van de Pol LA; Barkhof F; Scheltens P
J Alzheimers Dis; 2013; 36(1):79-85. PubMed ID: 23563246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
